According to Avadel Pharmaceuticals 's latest financial reports the company's total debt is $2.62 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $2.62 M | -98% |
2022-12-31 | $0.13 B | -9.64% |
2021-12-31 | $0.14 B | 11.09% |
2020-12-31 | $0.13 B | 4.71% |
2019-12-31 | $0.12 B | 7.61% |
2018-12-31 | $0.11 B | 43285.77% |
2017-12-31 | $0.26 M | -67.24% |
2016-12-31 | $0.81 M | -27.1% |
2015-12-31 | $1.11 M | -69.92% |
2014-12-31 | $3.71 M | -95.65% |
2013-12-31 | $85.54 M | 131.92% |
2012-12-31 | $36.88 M | 807.83% |
2011-12-31 | $4.06 M | 0.17% |
2010-12-31 | $4.05 M | 3.87% |
2009-12-31 | $3.9 M | 25.24% |
2008-12-31 | $3.11 M | -8.94% |
2007-12-31 | $3.42 M | -1.81% |
2006-12-31 | $3.48 M | -8.02% |
2005-12-31 | $3.79 M | 29.39% |
2004-12-31 | $2.93 M | 33.61% |
2003-12-31 | $2.19 M | -10.93% |
2002-12-31 | $2.46 M | 45.17% |
2001-12-31 | $1.69 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.32 B | 12,345.27% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |